Published in Pediatr Pulmonol on October 01, 2001
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax (2007) 2.60
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J Bacteriol (2005) 2.04
Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. J Pediatr (2008) 1.96
Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes. Am J Respir Crit Care Med (2014) 1.66
Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS One (2011) 1.58
Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One (2013) 1.49
Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment. Pediatr Radiol (2005) 1.48
Reducing bias in bacterial community analysis of lower respiratory infections. ISME J (2012) 1.46
Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis. Radiology (2009) 1.42
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial. J Cyst Fibros (2010) 1.37
Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis (2013) 1.34
The hierarchy quorum sensing network in Pseudomonas aeruginosa. Protein Cell (2014) 1.32
Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun (2007) 1.30
Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respir Res (2010) 1.20
Improving rate of decline of FEV1 in young adults with cystic fibrosis. Thorax (2005) 1.20
Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial. Pediatr Pulmonol (2010) 1.14
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis. Pediatr Pulmonol (2011) 1.10
Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax (2003) 1.06
Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros (2012) 1.05
Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun (2013) 1.05
Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol (2009) 1.05
Ten years of viral and non-bacterial serology in adults with cystic fibrosis. Epidemiol Infect (2007) 1.04
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study. Thorax (2012) 1.04
pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37. Proc Natl Acad Sci U S A (2014) 1.03
Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep (2015) 0.99
Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol (2008) 0.98
Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature. Eur J Clin Pharmacol (2004) 0.98
Influenza-associated cystic fibrosis pulmonary exacerbations. Chest (2009) 0.97
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor. Clin Infect Dis (2014) 0.94
Clinical applications of pulmonary delivery of antibiotics. Adv Drug Deliv Rev (2014) 0.93
Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. J Pediatr (2012) 0.93
The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome (2014) 0.91
Pseudomonas aeruginosa AES-1 exhibits increased virulence gene expression during chronic infection of cystic fibrosis lung. PLoS One (2011) 0.91
Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype. Thorax (2005) 0.90
Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain. J Clin Microbiol (2014) 0.90
Targeting bacterial integration host factor to disrupt biofilms associated with cystic fibrosis. J Cyst Fibros (2012) 0.90
Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population. Thorax (2006) 0.90
Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis. Eur J Hum Genet (2010) 0.89
Atypical cystic fibrosis--diagnostic and management dilemmas. J R Soc Med (2003) 0.88
Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatr Pulmonol (2010) 0.87
Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis. Respir Res (2012) 0.85
Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Ann Am Thorac Soc (2014) 0.85
Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response. BMC Infect Dis (2015) 0.85
Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load? PLoS One (2013) 0.84
A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation. Metabolomics (2013) 0.84
Uncovering symptom progression history from disease registry data with application to young cystic fibrosis patients. Biometrics (2009) 0.83
Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes. Pediatr Pulmonol (2010) 0.83
Links between Anr and Quorum Sensing in Pseudomonas aeruginosa Biofilms. J Bacteriol (2015) 0.82
Inhaled antibiotics in cystic fibrosis: what's new? J R Soc Med (2012) 0.82
Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis. Clin Med Insights Circ Respir Pulm Med (2013) 0.81
Delays in diagnosing cystic fibrosis: can we find ways to diagnose it earlier? Can Fam Physician (2008) 0.80
Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. J Clin Microbiol (2009) 0.80
Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis. Clin Infect Dis (2015) 0.80
Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis. Pediatr Pulmonol (2013) 0.79
Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting. Eur J Clin Microbiol Infect Dis (2013) 0.79
Pulmonary radiographic findings in young children with cystic fibrosis. Pediatr Radiol (2014) 0.79
Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis. Thorax (2006) 0.78
Environmental allergies and respiratory morbidities in cystic fibrosis. Pediatr Pulmonol (2012) 0.77
BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study. Clin Dev Immunol (2012) 0.77
Hospital versus home treatment of respiratory exacerbations in cystic fibrosis. Med Sci Monit (2011) 0.77
Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization. Springerplus (2015) 0.77
Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment. J Bras Pneumol (2013) 0.76
Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis. Ann Am Thorac Soc (2015) 0.76
Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis. J Cyst Fibros (2015) 0.76
Chelation of Membrane-Bound Cations by Extracellular DNA Activates the Type VI Secretion System in Pseudomonas aeruginosa. Infect Immun (2016) 0.75
Modular Approach to Select Bacteriophages Targeting Pseudomonas aeruginosa for Their Application to Children Suffering With Cystic Fibrosis. Front Microbiol (2016) 0.75
Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher. J Cyst Fibros (2017) 0.75
Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis. BMC Pulm Med (2017) 0.75
Changing incidence of cystic fibrosis in Wisconsin, USA. Pediatr Pulmonol (2015) 0.75
Nonparametric estimation of the mean function for recurrent event data with missing event category. Biometrika (2013) 0.75
A cross-sectional study of growth, nutritional status and body proportions in children and adolescents at a medical center specializing in the treatment of cystic fibrosis in Poland. Arch Med Sci (2015) 0.75
Editorial Commentary: Pseudomonas aeruginosa Eradication: How Do We Measure Success? Clin Infect Dis (2015) 0.75
BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients. J Immunol Res (2015) 0.75
Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis. BMC Pulm Med (2015) 0.75
Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre. Can Respir J (2016) 0.75
Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients. Infect Drug Resist (2014) 0.75
Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening. Pediatr Pulmonol (2016) 0.75
Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection. PLoS One (2017) 0.75
Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis. Pediatr Pulmonol (2017) 0.75
Pseudomonas aeruginosa and post-tracheotomy bacterial respiratory tract infection readmissions. Pediatr Pulmonol (2017) 0.75
A small cosmid for efficient cloning of large DNA fragments. Gene (1980) 22.61
Cosmids: a type of plasmid gene-cloning vector that is packageable in vitro in bacteriophage lambda heads. Proc Natl Acad Sci U S A (1978) 16.33
Structure and ligand of a histone acetyltransferase bromodomain. Nature (1999) 10.08
Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol (1977) 8.29
Neonatal salmonella meningitis complicated by cerebral abscesses. West J Med (1977) 5.55
Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci U S A (1993) 5.47
Accelerated titration designs for phase I clinical trials in oncology. J Natl Cancer Inst (1997) 4.60
School-based programs to reduce sexual risk behaviors: a review of effectiveness. Public Health Rep (1994) 4.50
Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics (2001) 4.26
Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol (1977) 4.09
Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol (1996) 4.02
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet (2000) 3.79
Plasmids useable as gene-cloning vectors in an in vitro packaging by coliphage lambda: "cosmids". Gene (1978) 3.66
Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens. Virology (1981) 3.61
Cloning of the complete human cytomegalovirus genome in cosmids. Gene (1982) 3.55
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol (2004) 3.29
Hyaline membrane disease. Am Rev Respir Dis (1975) 3.20
Structure and acetyl-lysine recognition of the bromodomain. Oncogene (2007) 3.20
Vfr controls quorum sensing in Pseudomonas aeruginosa. J Bacteriol (1997) 3.10
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer (1998) 3.03
Activation of a transposable element in the germ line but not the soma of Caenorhabditis elegans. Nature (1987) 3.00
Gonadotrophin stimulation test ovarian function. Br Med J (1968) 2.99
Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol (1999) 2.95
Response of Neisseria gonorrhoeae to iron limitation: alterations in expression of membrane proteins without apparent siderophore production. Infect Immun (1985) 2.94
Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. N Engl J Med (1997) 2.91
Organization and function of an accident flying squad. Br Med J (1966) 2.88
Instability of palindromic DNA in Escherichia coli. Cold Spring Harb Symp Quant Biol (1981) 2.75
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol (2006) 2.72
Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol (1999) 2.72
Escherichia coli plasmids packageable in vitro in lambda bacteriophage particles. Methods Enzymol (1979) 2.71
Fertility and ageing. Hum Reprod Update (2005) 2.68
Medium-dependent inhibition of Peptostreptococcus anaerobius by sodium polyanetholsulfonate in blood culture media. J Clin Microbiol (1976) 2.46
Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem (1999) 2.38
Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol (1999) 2.36
Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr (1992) 2.36
Sequence interruptions in enterobacterial repeated elements retain their ability to encode well-folded RNA secondary structures. Mol Microbiol (1997) 2.33
Free ribosomal DNA molecules from Tetrahymena pyriformis GL are giant palindromes. J Mol Biol (1976) 2.33
Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol (1998) 2.22
Precise and nearly-precise excision of the symmetrical inverted repeats of Tn5; common features of recA-independent deletion events in Escherichia coli. Gene (1983) 2.21
Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet (1995) 2.19
Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics (1990) 2.19
Safer choices: reducing teen pregnancy, HIV, and STDs. Public Health Rep (2001) 2.07
Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci U S A (1987) 1.98
Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur J Immunol (1996) 1.97
Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) (2011) 1.95
A case of asthma. Br Med J (1976) 1.95
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol (2000) 1.92
Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol (2000) 1.91
Relationship between chromosome replication and F'lac episome replication in Escherichia coli. J Mol Biol (1973) 1.89
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol (2000) 1.81
Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. N Engl J Med (2000) 1.78
Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol (2001) 1.78
The expression of tetracycline resistance after insertion of foreign DNA fragments between the EcoRI and HindIII sites of the plasmid cloning vector pBR 322. Mol Gen Genet (1978) 1.77
Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update (2006) 1.76
Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology (2013) 1.76
Gene cloning with small plasmids. Curr Top Microbiol Immunol (1977) 1.76
Two dominant mutations in the mouse fused gene are the result of transposon insertions. Genetics (1997) 1.76
Specificity of DnaK-peptide binding. J Mol Biol (1994) 1.75
Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin. J Clin Microbiol (1982) 1.75
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol (2003) 1.75
Cell-free synthesis of proteins coding for mobilisation functions of ColE1 and transposition functions of Tn3. Gene (1979) 1.74
Expression of Escherichia coli ribosomal protein and RNA polymerase genes cloned on plasmids. Mol Gen Genet (1979) 1.74
Aerobactin utilization by Neisseria gonorrhoeae and cloning of a genomic DNA fragment that complements Escherichia coli fhuB mutations. J Bacteriol (1987) 1.72
Phenotypic and molecular analysis of a transgenic insertional allele of the mouse Fused locus. Genetics (1995) 1.72
Towards less confusing terminology in reproductive medicine: a proposal. Hum Reprod (2004) 1.70
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol (1989) 1.69
Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet (1995) 1.68
Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc Natl Acad Sci U S A (1993) 1.67
Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update (2005) 1.66
Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr (1991) 1.66
Effect of systemic adjuvant treatment on first sites of breast cancer relapse. Lancet (1994) 1.64
Antenatal care of low risk obstetric patients by midwives. A randomised controlled trial. Med J Aust (1992) 1.60
Preliminary report on isolation of mycobacteria from patients with Crohn's disease. Dig Dis Sci (1989) 1.60
Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics (2001) 1.58
Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr (1998) 1.57
Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med (1998) 1.54
Just-in-time coding of the problem list in a clinical environment. Proc AMIA Symp (1998) 1.52
Progress in efforts to prevent the spread of HIV infection among youth. Public Health Rep (1992) 1.52
A census of copies of the first edition of Andreas Vesalius' De humani corporis fabrica (1543), with a note on the recently discovered variant issue. J Hist Med Allied Sci (1984) 1.52
Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res (1990) 1.51
Vaspar broth-disk procedure for antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1980) 1.50
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer. J Clin Oncol (2001) 1.49
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med (1999) 1.49
Characterization of DNA polymerase beta mRNA: cell-cycle and growth response in cultured human cells. Nucleic Acids Res (1988) 1.48
Polymorphisms in the toll-like receptor 9 gene associated with sepsis and multiple organ dysfunction after major blunt trauma. Br J Surg (2011) 1.48
Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J Dev Behav Pediatr (1992) 1.47
Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem J (1999) 1.45
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG) Ann Oncol (1995) 1.45
Hydroperoxide assay with the ferric-xylenol orange complex. Anal Biochem (1999) 1.45
The use of condoms with other contraceptive methods among young men and women. Fam Plann Perspect (1998) 1.44
Geographical variations in the epidemiology of bacterial sexually transmitted infections in Manitoba, Canada. Sex Transm Infect (2002) 1.43
Inducibility of human beta-interferon gene in mouse L-cell clones. Nature (1982) 1.43